Screener
Phathom Pharmaceuticals, Inc. PHAT Balance Sheet Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $184.56M+36.6% | $182.48M+22.0% | $180.9M-14.8% | $129.97M-56.3% | $135.16M-59.6% | ||
| $107.6M+92.9% | $97.42M+90.1% | $80.72M+122% | $78.13M+101% | $55.79M+165% | ||
| $27.33M+13.4% | $21.83M-11.5% | $19.08M-17.1% | $20.73M+79.7% | $24.1M+290% | ||
| $308.01M+48.2% | $295.92M+35.2% | $276.57M+4.4% | $228.97M-36.4% | $207.78M-44.4% | ||
| $935K-19.1% | $971K-21.8% | $1.02M-25.0% | $1.06M-27.9% | $1.16M-30.2% | ||
| $345.02M+43.6% | $327.08M+30.7% | $305.12M+3.7% | $259.15M-31.5% | $240.29M-37.9% | ||
| $11.11M+933% | $5.36M+33.8% | $6.37M-45.2% | $4.98M-52.6% | $1.08M-84.9% | ||
| $40.52M+66.4% | $37.28M+73.2% | $33.02M+91.2% | $27.25M+37.8% | $24.34M+20.6% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $174.9M+87.8% | $153.78M+67.5% | $125.04M+68.9% | $132.04M+54.0% | $93.12M+42.6% | ||
| $165.54M-20.1% | $164.59M-19.8% | $163.68M-19.5% | $209.09M+3.8% | $207.09M+17.8% | ||
| $692.66M+4.5% | $671.35M+2.3% | $642.08M+1.5% | $697.32M+10.4% | $662.82M+15.4% | ||
| $8K+33.3% | $8K+33.3% | $7K+16.7% | $6K0.0% | $6K0.0% | ||
| -$1.55B-5.7% | -$1.53B-6.9% | -$1.51B-11.6% | -$1.48B-17.5% | -$1.46B-23.1% | ||
| -$347.64M+17.7% | -$344.27M+15.2% | -$336.96M+0.4% | -$438.17M-72.8% | -$422.53M-126% | ||
| $345.02M+43.6% | $327.08M+30.7% | $305.12M+3.7% | $259.15M-31.5% | $240.29M-37.9% |
FAQ
- What are Phathom Pharmaceuticals, Inc.'s total assets?
- Phathom Pharmaceuticals, Inc. (PHAT) holds $345.0M in total assets, up 43.6% year over year.
- How much debt does Phathom Pharmaceuticals, Inc. have?
- Phathom Pharmaceuticals, Inc. carries $168.0M in total debt against -$347.6M of shareholders' equity, a debt-to-equity ratio of 5.64.
- How much cash does Phathom Pharmaceuticals, Inc. have?
- Phathom Pharmaceuticals, Inc. holds $184.6M in cash and equivalents.
- Can Phathom Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 1.76 — current assets exceed current liabilities.
- Where does Phathom Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Phathom Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
